Role of 18F-FDG PET in stage IV thyroid cancer with positive 131I whole body scan.

被引：0
|
作者：
Piccardo, A. [1 ]
Morbelli, S. [1 ]
Bianchi, P. [1 ]
Barbera, F. [1 ]
Villavecchia, G. [1 ]
Cabria, M. [1 ]
机构：
[1] Osped Galliera, Genoa, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2007年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S198 / S198
页数：1
相关论文
共 50 条
  • [1] 18F-FDG PET in the Management of Differentiated Thyroid Cancer in Patients with High Serum Thyroglobulin and Negative I-131 Whole Body Scan.
    Martins, R. G.
    Santos, A. P.
    Couto, J.
    Barbosa, A. P.
    Teixeira, J.
    Lucena, I.
    Bastos, L.
    Torres, I.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [2] Could [18]F-fluorodeoxyglucose PET/CT change the therapeutic management of stage IV thyroid cancer with positive 131I whole body scan?
    Piccardo, A.
    Foppiani, L.
    Morbelli, S.
    Bianchi, P.
    Barbera, F.
    Biscaldi, E.
    Altrinetti, V.
    Villavecchia, G.
    Cabria, M.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 55 (01): : 57 - 65
  • [3] Comparison of 131I whole-body imaging, 131I SPECT/CT, and 18F-FDG PET/CT in the detection of metastatic thyroid cancer
    Oh, Jong-Ryool
    Byun, Byung-Hyun
    Hong, Sun-Pyo
    Chong, Ari
    Kim, Jahae
    Yoo, Su-Woong
    Kang, Sae-Ryung
    Kim, Dong-Yeon
    Song, Ho-Chun
    Bom, Hee-Seung
    Min, Jung-Joon
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (08) : 1459 - 1468
  • [4] Comparison of 131I whole-body imaging, 131I SPECT/CT, and 18F-FDG PET/CT in the detection of metastatic thyroid cancer
    Jong-Ryool Oh
    Byung-Hyun Byun
    Sun-Pyo Hong
    Ari Chong
    Jahae Kim
    Su-Woong Yoo
    Sae-Ryung Kang
    Dong-Yeon Kim
    Ho-Chun Song
    Hee-Seung Bom
    Jung-Joon Min
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1459 - 1468
  • [5] Thymic uptake in 131I (131I) whole body scan.
    Yeung, HW
    Pandit-Taskar, N
    Simon, J
    Larson, SM
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 323P - 323P
  • [6] Concurrent 131I whole body scan and FDG whole body PET study of recurrent thyroid cancer.
    Chu, LS
    Liu, RS
    Sun, CM
    Chang, CP
    Lee, CH
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 9P - 9P
  • [7] Value of 18F-FDG Hybrid PET/MR in Differentiated Thyroid Cancer Patients with Negative 131I Whole-Body Scan and Elevated Thyroglobulin Levels
    Li, Hongyan
    Chen, Xiaomin
    Zhang, Yajing
    Wang, Kun
    Gao, Zairong
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2869 - 2876
  • [8] Complementary values of [18F]-FDG PET and 131I whole body scan in characterization of thyroid carcinoma and in the choice of therapy
    Taieb, D.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (01): : 34 - 35
  • [9] Role of PET/CT 18F-FDG in the assessment of differentiated thyroid cancer in patients with negative 131I post-therapy whole body scan and elevated serum thyroglobulin levels
    Vieira, F.
    Azevedo-Silva, F.
    Parracho, M.
    Costa, G.
    Lapa, P.
    Albuquerque, A.
    Pedroso-Lima, J.
    Ferrer-Antunes, A. I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S121 - S121
  • [10] Comparison of whole-body 18F-FDG SPECT and posttherapeutic 131I scintigraphy in the detection of metastatic thyroid cancer
    Wang, Hui
    Fu, Hong Liang
    Li, Ha Ning
    Zhou, Ren Han
    Gu, Zhen Hui
    Wu, Jing Chuan
    Huang, Gang
    CLINICAL IMAGING, 2008, 32 (01) : 32 - 37
12345